Jennifer Humes's most recent trade in Roivant Sciences Ltd was a trade of 29,173 Common Shares done . Disclosure was reported to the exchange on April 20, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Roivant Sciences Ltd | Jennifer Humes | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 29,173 | 113,364 | - | 0 | Common Shares | |
| Roivant Sciences Ltd | Jennifer Humes | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 27,157 | 27,157 | - | - | Stock Option (Right to Buy) | |
| Roivant Sciences Ltd | Jennifer Humes | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 28.37 per share. | 08 Apr 2026 | 13,538 | 84,191 | - | 28.4 | 384,073 | Common Shares |
| Roivant Sciences Ltd | Jennifer Humes | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.70 per share. | 20 Mar 2026 | 14,526 | 97,729 | - | 27.7 | 402,370 | Common Shares |
| Roivant Sciences Ltd | Jennifer Humes | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2025 | 115,108 | 115,108 | - | - | Stock Option (Right to Buy) | |
| Roivant Sciences Ltd | Jennifer Humes | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2025 | 112,255 | 112,255 | - | 0 | Common Shares |